Investors Await the Fed, Biotech’s Best Year Ever, and Robinhood Gets Sued

<p>Strategists and economists join with a look at the Fed’s unprecedented year—what worked, what didn’t and what investors can expect in 2021. </p><p>Biotech was the big winner in 2020, a top analyst has his picks for next year. </p><p>And Massachusetts suing investing app Robinhood, alleging it gamifies markets and manipulates investors…we get a look at the potential fallout. </p>